Current Rating and Its Significance
MarketsMOJO currently assigns Albert David Ltd a 'Hold' rating, reflecting a balanced view of the stock’s prospects. This rating suggests that investors should maintain their existing positions rather than aggressively buying or selling the stock at this time. The 'Hold' status indicates that while the company shows promising financial trends, certain factors such as valuation and quality metrics temper the enthusiasm for a stronger recommendation.
Rating Update Context
The rating was revised from 'Sell' to 'Hold' on 07 August 2026, accompanied by a significant improvement in the Mojo Score, which rose by 24 points from 43 to 67. This change signals a more favourable outlook compared to previous assessments, but it is important to note that all fundamentals, returns, and financial metrics referenced here are current as of 21 August 2026, ensuring investors have the most up-to-date information.
Quality Assessment
Albert David Ltd’s quality grade is classified as average. The company operates in the Pharmaceuticals & Biotechnology sector and is currently net-debt free, which is a positive indicator of financial stability. However, long-term growth has been a challenge, with operating profit declining at an annualised rate of -7.82% over the past five years. This suggests that while the company maintains operational soundness, it faces headwinds in sustaining consistent profitability growth over the longer term.
Valuation Considerations
The stock’s valuation is deemed fair, trading at a price-to-book value of 1.3. This places Albert David Ltd at a premium relative to its peers’ historical averages, reflecting some market confidence in its prospects. The return on equity (ROE) stands at 5.8%, which is modest but acceptable within the sector context. Investors should note that the price-to-earnings-to-growth (PEG) ratio is an attractive 0.1, indicating that the stock’s price growth is currently undervalued relative to its earnings growth potential.
Financial Trend and Recent Performance
The company’s financial trend is very positive, with recent results demonstrating strong growth momentum. As of 21 August 2026, Albert David Ltd reported a remarkable 303.02% increase in net profit, underscoring a significant turnaround in profitability. Profit before tax (PBT) excluding other income for the latest quarter was ₹7.83 crores, growing at 157.57%. Net sales for the latest six months reached ₹187.20 crores, reflecting a 28.70% increase, while profit after tax (PAT) for the same period rose to ₹10.57 crores. These figures highlight a robust recovery and operational improvement that support the current 'Hold' rating.
Technical Analysis
From a technical standpoint, the stock exhibits mildly bullish characteristics. Over the past month, Albert David Ltd’s share price has appreciated by 23.59%, with a six-month gain of 17.16% and a year-to-date return of 15.74%. The one-year return stands at 4.73%, indicating moderate but steady upward momentum. Despite a slight dip of 1.01% on the most recent trading day, the overall trend remains positive, suggesting that technical indicators support the current valuation and rating.
Shareholding and Market Capitalisation
Albert David Ltd is classified as a microcap company within the Pharmaceuticals & Biotechnology sector. The majority of shares are held by promoters, which often implies a stable ownership structure and potential alignment of interests with minority shareholders. This ownership concentration can be a factor in the company’s strategic decisions and long-term planning.
Investment Implications
For investors, the 'Hold' rating on Albert David Ltd suggests a cautious approach. The company’s recent financial improvements and positive technical signals are encouraging, yet the average quality grade and fair valuation indicate that the stock may not offer significant upside in the near term. Investors should monitor ongoing operational performance and sector developments to reassess the stock’s potential for upgrade to a more favourable rating.
While markets shift, this one's charging ahead! This Micro Cap from Aquaculture shows the strongest momentum signals in current conditions. Don't miss out on this ride!
- - Strongest current momentum
- - Market-cycle outperformer
- - Aquaculture sector strength
Summary of Key Metrics as of 21 August 2026
The latest data shows that Albert David Ltd has delivered a one-month return of 23.59% and a three-month return of 21.22%, outperforming many peers in the Pharmaceuticals & Biotechnology sector. The company’s net sales growth of 28.70% over the last six months and a net profit surge of over 300% reflect strong operational execution. Despite these positives, the long-term operating profit decline and average quality grade suggest that investors should maintain a balanced view.
Outlook and Considerations
Looking ahead, Albert David Ltd’s prospects will depend on its ability to sustain profit growth and improve operational efficiency. The fair valuation and mild bullish technical indicators provide a foundation for potential gains, but investors should remain vigilant for any sector headwinds or company-specific risks. The 'Hold' rating thus serves as a prudent recommendation, signalling that the stock is fairly valued given current fundamentals and market conditions.
Conclusion
In conclusion, Albert David Ltd’s 'Hold' rating by MarketsMOJO reflects a nuanced assessment of its current financial health, valuation, and market momentum. While recent results are encouraging and technical trends supportive, the company’s average quality and fair valuation warrant a cautious stance. Investors are advised to monitor ongoing developments closely and consider this rating as guidance to maintain existing positions rather than initiate new ones at this stage.
Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today
